KIMBERLY STEPNEY: Open Payments
NPI 1205403185 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 41 payments from 16 companies in 2025. Trend: 2023 $1,252 · 2024 $1,106 · 2025 $941
Food & beverage: $941
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $237 |
| AstraZeneca Pharmaceuticals LP | 9 | $203 |
| Alnylam Pharmaceuticals Inc. | 2 | $65 |
| Novo Nordisk Inc | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| BridgeBio Pharma, Inc. | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $40 |
| Amgen Inc. | 2 | $38 |
| Mannkind Corporation | 1 | $35 |
Products named: Kerendia, WAINUA, FARXIGA, Wegovy, LEQVIO, Attruby, CAMZYOS, LifeVest.
Industry payments across NC — which companies pay providers there.
